BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 26631583)

  • 1. Interaction of GABA-mimetics with the taurine transporter (TauT, Slc6a6) in hyperosmotic treated Caco-2, LLC-PK1 and rat renal SKPT cells.
    Rasmussen RN; Lagunas C; Plum J; Holm R; Nielsen CU
    Eur J Pharm Sci; 2016 Jan; 82():138-46. PubMed ID: 26631583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Function of taurine transporter (Slc6a6/TauT) as a GABA transporting protein and its relevance to GABA transport in rat retinal capillary endothelial cells.
    Tomi M; Tajima A; Tachikawa M; Hosoya K
    Biochim Biophys Acta; 2008 Oct; 1778(10):2138-42. PubMed ID: 18501699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino acid residues involved in the substrate specificity of TauT/SLC6A6 for taurine and γ-aminobutyric acid.
    Yahara T; Tachikawa M; Akanuma S; Kubo Y; Hosoya K
    Biol Pharm Bull; 2014; 37(5):817-25. PubMed ID: 24790004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotransmitter transporter family including SLC6A6 and SLC6A13 contributes to the 5-aminolevulinic acid (ALA)-induced accumulation of protoporphyrin IX and photodamage, through uptake of ALA by cancerous cells.
    Tran TT; Mu A; Adachi Y; Adachi Y; Taketani S
    Photochem Photobiol; 2014; 90(5):1136-43. PubMed ID: 24842606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taurine uptake across the human intestinal brush-border membrane is via two transporters: H+-coupled PAT1 (SLC36A1) and Na+- and Cl(-)-dependent TauT (SLC6A6).
    Anderson CM; Howard A; Walters JR; Ganapathy V; Thwaites DT
    J Physiol; 2009 Feb; 587(Pt 4):731-44. PubMed ID: 19074966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relative roles of external taurine concentration and medium osmolality in the regulation of taurine transport in LLC-PK1 and MDCK cells.
    Jones DP; Miller LA; Chesney RW
    Pediatr Res; 1995 Feb; 37(2):227-32. PubMed ID: 7537366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carrier-mediated γ-aminobutyric acid transport across the basolateral membrane of human intestinal Caco-2 cell monolayers.
    Nielsen CU; Carstensen M; Brodin B
    Eur J Pharm Biopharm; 2012 Jun; 81(2):458-62. PubMed ID: 22452873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-epileptic drug substance vigabatrin inhibits taurine transport in intestinal and renal cell culture models.
    Plum J; Nøhr MK; Hansen SH; Holm R; Nielsen CU
    Int J Pharm; 2014 Oct; 473(1-2):395-7. PubMed ID: 25062867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of TauT by calcitriol and retinoic acid via VDR/RXR in LLC-PK1 and MCF-7 cells.
    Chesney RW; Han X
    Adv Exp Med Biol; 2013; 776():291-305. PubMed ID: 23392891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmembrane domains I and II of the gamma-aminobutyric acid transporter GAT-4 contain molecular determinants of substrate specificity.
    Melamed N; Kanner BI
    Mol Pharmacol; 2004 Jun; 65(6):1452-61. PubMed ID: 15155838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of expression of taurine transport in two continuous renal epithelial cell lines and inhibition of taurine transporter by a site-directed antibody.
    Han X; Chesney RW; Budreau AM; Jones DP
    Adv Exp Med Biol; 1996; 403():173-91. PubMed ID: 8915355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assembly of Taurine Transporter (Slc6a6) with Na
    Tachikawa M; Yokoyama R; Akanuma SI; Hosoya KI
    Biol Pharm Bull; 2018; 41(3):338-341. PubMed ID: 29491210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imidazole-4-acetic acid, a new lead structure for interaction with the taurine transporter in outer blood-retinal barrier cells.
    Valembois S; Krall J; Frølund B; Steffansen B
    Eur J Pharm Sci; 2017 May; 103():77-84. PubMed ID: 28259832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyperglycemia inhibited taurine transport and taurine transporter gene expression in cultured rat cardiomyocytes].
    Shi YR; Gao L; Wang SH; Pang YZ; Tang C
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2003 May; 19(2):132-6. PubMed ID: 21207658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of competitive inhibitors of the human taurine transporter TauT in a human kidney cell line.
    Richter M; Moroniak SJ; Michel H
    Pharmacol Rep; 2019 Feb; 71(1):121-129. PubMed ID: 30612046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible expression of a particular gamma-aminobutyric acid transporter isoform responsive to upregulation by hyperosmolarity in rat calvarial osteoblasts.
    Fujimori S; Hinoi E; Takarada T; Iemata M; Takahata Y; Yoneda Y
    Eur J Pharmacol; 2006 Nov; 550(1-3):24-32. PubMed ID: 17022965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the expression and subcellular localization of the taurine transporter TauT in mouse NIH3T3 fibroblasts.
    Voss JW; Pedersen SF; Christensen ST; Lambert IH
    Eur J Biochem; 2004 Dec; 271(23-24):4646-58. PubMed ID: 15606752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of TauT by cisplatin in LLC-PK1 renal cells.
    Han X; Chesney RW
    Pediatr Nephrol; 2005 Aug; 20(8):1067-72. PubMed ID: 15942793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Β-alanine and l-histidine transport across the inner blood-retinal barrier: potential involvement in L-carnosine supply.
    Usui T; Kubo Y; Akanuma S; Hosoya K
    Exp Eye Res; 2013 Aug; 113():135-42. PubMed ID: 23773890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osmoregulation of taurine transporter function and expression in retinal pigment epithelial, ganglion, and müller cells.
    El-Sherbeny A; Naggar H; Miyauchi S; Ola MS; Maddox DM; Martin PM; Ganapathy V; Smith SB
    Invest Ophthalmol Vis Sci; 2004 Feb; 45(2):694-701. PubMed ID: 14744916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.